SAN FRANCISCO, April 18, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Inari Medical, Inc. (NASDAQ:NARI) investors who suffered substantial losses to submit your losses now.
Visit: www.hbsslaw.com/investor-fraud/nari
Contact An Attorney Now: NARI@hbsslaw.com
844-916-0895
Inari Medical, Inc. (NARI) Investigation:
Last month, Inari Medical spooked analysts after the medical device company revealed it was being investigated by the DOJ over certain payments to healthcare professionals and warned that "[d]epending on the outcome of the Investigation, there may be a material impact on our business, results of operations, or financial condition."
Scrutinizing the disclosure, Piper Sandler wrote in a Feb. 29, 2024 report, "NARI disclosed on the EPS call that in December 2023, the company received a civil investigative demand from the U.S. DOJ requesting information primarily related to meals and consulting service payments provided ...